Quantcast

Latest Hemodialysis Stories

2014-08-20 23:02:26

A common approach to treating kidney failure by removing waste products from the blood did not improve survival chances for people who suddenly developed the condition, in a new analysis led by experts at the University of Pittsburgh School of Medicine. Pittsburgh, PA (PRWEB) August 20, 2014 A common approach to treating kidney failure by removing waste products from the blood did not improve survival chances for people who suddenly developed the condition, in an analysis led by experts...

2014-08-18 16:28:18

Second Phase 3 Registrational Study Meets Primary and All Secondary Endpoints THOUSAND OAKS, Calif., Aug. 18, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that a second placebo-controlled Phase 3 study evaluating AMG 416 for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), receiving hemodialysis, met its primary and all secondary endpoints. The primary endpoint was the proportion of patients with > 30 percent...

2014-08-14 20:22:56

RIVER EDGE, N.J., Aug. 14, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three and six months ended June 30, 2014. Recent Highlights -- First commercial use of the Nephros on-line mid-dilution hemodiafiltration...

2014-08-14 16:27:40

Signs Business Collaboration in South Korea with Wonik Corporation BRIDGEWATER, N.J., Aug. 14, 2014 /PRNewswire/ -- CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal and infectious disease, today announced the U.S. Food and Drug Administration (FDA) has agreed with the design of our pivotal Phase III protocol for Neutrolin® in Hemodialysis patients, and the company...

2014-08-12 04:21:14

Four internationally renowned renal care specialists to assist Quanta as it prepares for the clinical introduction of its advanced haemodialysis system ALCESTER, England, August 12, 2014 /PRNewswire/ -- Quanta Fluid Solutions Ltd ("Quanta" or the "Company"), a pioneering developer of advanced haemodialysis systems, today announces it has appointed four leading renal experts to its newly established Medical Advisory Board. Prof. John Agar, Dr. Roger Greenwood, Dr. Clara Day and...

2014-08-07 04:21:45

ALCESTER, England, August 7, 2014 /PRNewswire/ -- Quanta Fluid Solutions Ltd ("Quanta" or the "Company"), a pioneering developer of advanced haemodialysis systems, today announces the appointment of Willem Baralt as Chief Financial Officer. Willem has almost twenty years of investment banking, executive management and private equity experience. Amongst his achievements, Willem was pivotal in the $1.6billion turnaround and public listing of FLAG Telecom and was...

2014-08-05 08:35:12

ATLANTA, Aug. 5, 2014 /PRNewswire/ --CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it will participate in the upcoming 34(th) Annual Canaccord Genuity Growth Conference on Wednesday, August 13, 2014 at the InterContinental Boston Hotel. http://photos.prnewswire.com/prnvar/20140319/MM86518LOGO A live webcast of the Company's presentation is scheduled to begin at 8:00 a.m. ET and will...

2014-07-30 16:29:56

ATLANTA, July 30, 2014 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that its Board of Directors has approved a quarterly cash dividend for the third quarter 2014 of $0.03 per share of common stock outstanding. The quarterly cash dividend of $0.03 per share will be paid on September 19, 2014 to all common stockholders of record as of September 12, 2014. The ex-dividend date...

2014-07-30 08:32:14

SAN ANTONIO, July 30, 2014 /PRNewswire/ -- Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, today announced it has closed $4.5 million in Series A financing, which was led by Targeted Technology Fund II. Proceeds from the deal will allow Bluegrass Vascular to obtain CE Mark for the Surfacer(TM) Inside-Out Access Catheter System, enhance manufacturing capabilities, and proceed with US...

2014-07-24 08:34:37

RnRMarketResearch.com adds "Market Research Report on Global and Chinese Hemodialysis Machine Industry, 2009-2019" to its store. DALLAS, July 24, 2014 /PRNewswire-iReach/ -- Delivery of the Report will take 2-3 working days once order is placed. Photo - http://photos.prnewswire.com/prnh/20140723/129707 This is a professional and in-depth market survey on Global and Chinese Hemodialysis Machine industry. The report firstly reviews the basic information of Hemodialysis Machine...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related